Carbapenem-resistant Enterobacterales (CRE) colonisation as a predictor for subsequent CRE infection: A retrospective surveillance study

被引:0
|
作者
Tubb, Courtney M. [1 ]
Tubb, Marco [1 ]
Hooijer, Jonathan [1 ]
Chomba, Rispah [2 ]
Nel, Jeremy [1 ]
机构
[1] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa
[2] Univ Witwatersrand, Sch Pathol, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa
关键词
CRE Enterobacterales; CRE colonisation; CRE infection; Antibiotic; Carbapenamase; carbapenem resistance; ANTIMICROBIAL RESISTANCE; RISK-FACTORS; BACTEREMIA; MECHANISMS;
D O I
10.4102/sajid.v40i1.687
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Carbapenem-resistant Enterobacterales (CRE) are associated with significant morbidity and mortality. Carbapenem-resistant Enterobacterales colonisation is an important prerequisite for infection, and its surveillance is crucial to reduce spread. However, data from South Africa are limited. Objectives: We aimed to determine CRE colonisation prevalence, the incidence of subsequent CRE infections and the risk factors associated with each. Method: We retrospectively reviewed hospital records from 686 patients admitted to a medical high-care ward at a tertiary hospital in Gauteng, South Africa, between October 2019 and May 2022. Patients were grouped by CRE colonisation status on arrival and discharge. Data on comorbidities, indwelling devices and antibiotic exposure were collected. Results: The prevalence of CRE colonisation was 12.4% (95% confidence interval [CI]: 10.1-15.1), with Klebsiella pneumoniae (81.2%) being the most common CRE isolated and OXA-48-like enzymes (94.5%) being the most frequent carbapenemase detected. Risk factors for CRE colonisation on the univariate analysis included exposure to antibiotics (odds ratio [OR]: 2.21; 95% CI: 0.98-4.96, P = 0.048) and presence of a central venous line (OR: 6.33; 95% CI: 1.78-22.46, P = 0.001). Of patients colonised with a CRE, 21.2% subsequently developed a culture-positive infection within 180 days from the initial colonisation result and the majority within 30 days. These infections were mostly CREs (OR: 4.0, 95% CI: 1.3-12.7), and where the infections were CREs, the causative CRE organism and carbapenemase subtype were identical in each case. Conclusion: Our study documented higher CRE prevalence rates than those previously reported from South Africa. Given the association between CRE colonisation and subsequent infection, urgent measures are required to reduce CRE colonisation rates. As the organism and carbapenemase detected in the initial colonisation and subsequent CRE infection were closely related, knowledge of prior CRE colonisation may assist clinicians with antibiotic choice if patients present with an infection within 30 days of CRE colonisation. Contribution: This study reports higher CRE colonization rates in South Africa than previously documented, highlighting the urgent need to reduce colonization. The close genetic link between CRE colonization and subsequent infection suggests that knowledge of prior colonization can guide clinicians in selecting effective antibiotics, particularly for infections occurring within 30 days. These findings support targeted interventions to address the rising CRE threat.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] High prevalence of carbapenem-resistant Enterobacterales (CRE) in human samples from Nigeria: A systematic review and meta-analysis
    Irekeola, Ahmad Adebayo
    Shueb, Rafidah Hanim
    Rahman, Engku Nur Syafirah Engku Abd
    Afolabi, Hafeez Abiola
    Wada, Yusuf
    Elmi, Abdirahman Hussein
    Hakami, Muath Abdu
    Alghzwani, Sfeeah Mofareah
    Elnoubi, Osman AE.
    Alshehri, Ahmad A.
    HELIYON, 2024, 10 (14)
  • [42] Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection
    Freire, Maristela P.
    Carvalho, Laina B.
    Reusing, Jose Otto, Jr.
    Spadao, Fernanda
    Lopes, Max Igor B. F.
    Nahas, William C.
    David-Neto, Elias
    Pierrotti, Ligia C.
    INFECTIOUS DISEASES, 2021, 53 (06) : 430 - 439
  • [43] Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States
    Bartsch, S. M.
    McKinnell, J. A.
    Mueller, L. E.
    Miller, L. G.
    Gohil, S. K.
    Huang, S. S.
    Lee, B. Y.
    CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (01) : 48.e9 - 48.e16
  • [44] Carbapenem-resistant Enterobacterales bacteriuria and subsequent bacteremia: A population-based study
    Howard-Anderson, Jessica R.
    Bower, Chris W.
    Smith, Gillian
    Sexton, Mary Elizabeth
    Farley, Monica M.
    Satola, Sarah W.
    Jacob, Jesse T.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (08): : 962 - 967
  • [45] Trimethoprim-sulfamethoxazole for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections
    Bandali, Aiman
    Bias, Tiffany E.
    INFECTIOUS DISEASES, 2019, 51 (06) : 456 - 458
  • [46] Active surveillance and molecular epidemiological study of intestinal colonization of carbapenem-resistant Enterobacterales
    储雯雯
    ChinaMedicalAbstracts(InternalMedicine), 2021, 38 (04) : 203 - 203
  • [47] Reducing Carbapenem Resistant Enterobacterales (CRE) Hospital Acquired Infections by Implementing a Prevention Bundle
    Dolan, B.
    Dawson, S.
    Lee, Y.
    Miyakawa, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [48] Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) in healthcare and community settings in Botswana: an antibiotic resistance in communities and hospitals (ARCH) study
    Mannathoko, Naledi
    Mosepele, Mosepele
    Gross, Robert
    Smith, Rachel M.
    Alby, Kevin
    Glaser, Laurel
    Richard-Greenblatt, Melissa
    Dumm, Rebekah
    Sharma, Aditya
    Jaskowiak-Barr, Anne
    Cressman, Leigh
    Sewawa, Kgotlaetsile
    Cowden, Laura
    Reesey, Emily
    Otukile, Dimpho
    Paganotti, Giacomo M.
    Mokomane, Margaret
    Lautenbach, Ebbing
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 313 - 320
  • [49] Carbapenem-resistant Enterobacterales colonization and subsequent infection in a neonatal intensive care unit in Shanghai, China
    Yin, L.
    He, L.
    Miao, J.
    Yang, W.
    Wang, X.
    Ma, J.
    Wu, N.
    Cao, Y.
    Wang, C.
    INFECTION PREVENTION IN PRACTICE, 2021, 3 (03)
  • [50] Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States
    Satlin, Michael J.
    Chen, Liang
    Patel, Gopi
    Gomez-Simmonds, Angela
    Weston, Gregory
    Kim, Angela C.
    Seo, Susan K.
    Rosenthai, Marnie E.
    Sperber, Steven J.
    Jenkins, Stephen G.
    Hamula, Camille L.
    Uhlemann, Anne-Catrin
    Levi, Michael H.
    Fries, Bettina C.
    Tang, Yi-Wei
    Juretschko, Stefan
    Rojtman, Albert D.
    Hong, Tao
    Mathema, Barun
    Jacobs, Michael R.
    Walsh, Thomas J.
    Bonomo, Robert A.
    Kreiswirth, Barry N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (04)